Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
Modified Vaccinia Ankara Bavarian Nordic (MVA-BN) as a smallpox and mpox vaccine has been approved in its liquid-frozen (LF) formulation in the US, Canada, and EU. A freeze-dried (FD) formulation may offer additional benefits, such as a longer shelf life and reduced dependence on cold chain storage...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2024-12-01
|
| Serier: | Human Vaccines & Immunotherapeutics |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2384189 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
